Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Tafasitamab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InnoCare’s Minjuvi Combo Approved in China
    InnoCare’s Minjuvi Combo Approved in China

    21 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250521528560/en/InnoCare-Announces-the-Approval-of-Minjuvi-Tafasitamab-in-Combination-with-Lenalidomide-for-the-treatment-of-Adult-Patients-with-Relapsed-or-Refractory-Diffuse-Large-B-Cell-Lymphoma-in-China

    BUSINESSWIRE
    21 May 2025
    Share Share
    Incyte Monjuvi Data Shows Improved Survival In Follicular Lymphoma
    Incyte Monjuvi Data Shows Improved Survival In Follicular Lymphoma

    10 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210526828/en

    BUSINESSWIRE
    10 Dec 2024
    Share Share
    Incyte's Monjuvi proves its worth in follicular lymphoma
    Incyte's Monjuvi proves its worth in follicular lymphoma

    26 Nov 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/incytes-monjuvi-wins-big-follicular-lymphoma-phase-3-padding-upcoming-fda-filing

    FIERCE PHARMA
    26 Nov 2024
    Share Share
    Incyte to Present New Tafasitamab Data at 2024 ASH Annual Meeting
    Incyte to Present New Tafasitamab Data at 2024 ASH Annual Meeting

    25 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241125630696/en

    BUSINESSWIRE
    25 Nov 2024
    Share Share
    Incyte Seeks Monjuvi Label Expansion After Phase 3 Lymphoma Win
    Incyte Seeks Monjuvi Label Expansion After Phase 3 Lymphoma Win

    19 Aug 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/incyte-looks-widen-monjuvis-net-label-expansion-bid-after-phase-3-lymphoma-win

    FIERCE PHARMA
    19 Aug 2024
    Share Share
    Incyte Announces Positive Results From Tafasitamab Study In Follicular Lymphoma
    Incyte Announces Positive Results From Tafasitamab Study In Follicular Lymphoma

    15 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240815184197/en

    BUSINESSWIRE
    15 Aug 2024
    Share Share